ASX - By Stock
|
ZIP |
Re:
This is not going to end well.
|
|
Jambon1
|
37 |
6.6K |
0 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
37
|
6.6K
|
0
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: ZIP Completes A$217M Equity Placement at 2.8% Discount
|
|
Jambon1
|
70 |
17K |
1 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
70
|
17K
|
1
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: ZIP Completes A$217M Equity Placement at 2.8% Discount
|
|
Jambon1
|
70 |
17K |
3 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
70
|
17K
|
3
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: ZIP Completes A$217M Equity Placement at 2.8% Discount
|
|
Jambon1
|
70 |
17K |
6 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
70
|
17K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
Jambon1
|
554 |
196K |
5 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
554
|
196K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
Jambon1
|
554 |
196K |
8 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
554
|
196K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
Jambon1
|
554 |
196K |
4 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
554
|
196K
|
4
|
|
ASX - By Stock
|
LTP |
Re:
Ann: SPONTAN achieves positive clinical study results
|
|
Jambon1
|
180 |
62K |
2 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
180
|
62K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Jambon1
|
2.2K |
756K |
4 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
2.2K
|
756K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Jambon1
|
662 |
204K |
7 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
662
|
204K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Jambon1
|
2.2K |
756K |
5 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
2.2K
|
756K
|
5
|
|
ASX - By Stock
|
PLY |
Re:
Ann: Game of Thrones Real-Time Strategy Game in Development
|
|
Jambon1
|
11 |
3.9K |
0 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
11
|
3.9K
|
0
|
|
ASX - By Stock
|
PLY |
Re:
Ann: Game of Thrones Real-Time Strategy Game in Development
|
|
Jambon1
|
11 |
3.9K |
0 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
11
|
3.9K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Professor Erin Howden Joins Race Oncology SAB
|
|
Jambon1
|
22 |
10K |
48 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
22
|
10K
|
48
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Professor Erin Howden Joins Race Oncology SAB
|
|
Jambon1
|
22 |
10K |
23 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
22
|
10K
|
23
|
|
ASX - By Stock
|
EMD |
Re:
Emyria and Reach Wellness Launch
|
|
Jambon1
|
10 |
2.7K |
8 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
10
|
2.7K
|
8
|
|
ASX - By Stock
|
EMD |
Re:
general talk
|
|
Jambon1
|
349 |
122K |
1 |
03/03/24 |
03/03/24 |
ASX - By Stock
|
349
|
122K
|
1
|
|
ASX - By Stock
|
PLY |
Re:
Ann: PlaySide Publishing signs viral sensation MOUSE
|
|
Jambon1
|
3 |
2.0K |
0 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
3
|
2.0K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: December 2023 Quarterly Activities Report and Appendix 4C
|
|
Jambon1
|
50 |
16K |
4 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
50
|
16K
|
4
|
|
ASX - By Stock
|
RMD |
Re:
GLP-1 and OSA
|
|
Jambon1
|
93 |
51K |
1 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
93
|
51K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria Gets $2M Bids, Sets $3.1M Entitlement Offer
|
|
Jambon1
|
56 |
18K |
1 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
56
|
18K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Pax Centre Acquisition to Advance Psychedelic Therapies
|
|
Jambon1
|
39 |
10K |
4 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
39
|
10K
|
4
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria, Aspen Sign Binding Commercial Term Sheet for EMD-RX5
|
|
Jambon1
|
28 |
9.1K |
1 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
28
|
9.1K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emyria, Aspen Sign Binding Commercial Term Sheet for EMD-RX5
|
|
Jambon1
|
28 |
9.1K |
1 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
28
|
9.1K
|
1
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Jambon1
|
11K |
3.9M |
25 |
16/02/23 |
16/02/23 |
General
|
11K
|
3.9M
|
25
|
|
ASX - By Stock
|
EMD |
Re:
(TGA) will permit the prescribing of MDMA 1st July
|
|
Jambon1
|
125 |
33K |
6 |
04/02/23 |
04/02/23 |
ASX - By Stock
|
125
|
33K
|
6
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Biotech Showcase San Francisco Presentation
|
|
Jambon1
|
31 |
8.2K |
0 |
14/01/23 |
14/01/23 |
ASX - By Stock
|
31
|
8.2K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Ethics submission to commence cardioprotection trial
|
|
Jambon1
|
61 |
23K |
11 |
11/12/22 |
11/12/22 |
ASX - By Stock
|
61
|
23K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Ethics submission to commence cardioprotection trial
|
|
Jambon1
|
61 |
23K |
6 |
11/12/22 |
11/12/22 |
ASX - By Stock
|
61
|
23K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Ethics submission to commence cardioprotection trial
|
|
Jambon1
|
61 |
23K |
1 |
10/12/22 |
10/12/22 |
ASX - By Stock
|
61
|
23K
|
1
|
|
ASX - By Stock
|
PLY |
Re:
Ann: Mixed Reality Game Development Partnership with Meta
|
|
Jambon1
|
14 |
5.3K |
5 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
14
|
5.3K
|
5
|
|
ASX - By Stock
|
PLY |
Re:
Ann: Mixed Reality Game Development Partnership with Meta
|
|
Jambon1
|
14 |
5.3K |
5 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
14
|
5.3K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Jambon1
|
2.2K |
756K |
9 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
2.2K
|
756K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Jambon1
|
2.2K |
756K |
20 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
2.2K
|
756K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Jambon1
|
27 |
9.8K |
90 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
27
|
9.8K
|
90
|
|
ASX - By Stock
|
FFF |
Re:
Ann: Appendix 4E and Annual Report to Shareholders
|
|
Jambon1
|
2 |
1.2K |
1 |
06/09/22 |
06/09/22 |
ASX - By Stock
|
2
|
1.2K
|
1
|
|
ASX - By Stock
|
PLY |
Re:
Ann: FY2022 Results Media Release
|
|
Jambon1
|
3 |
2.2K |
4 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
3
|
2.2K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 4E & Annual Report
|
|
Jambon1
|
33 |
14K |
3 |
28/08/22 |
28/08/22 |
ASX - By Stock
|
33
|
14K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 4E & Annual Report
|
|
Jambon1
|
33 |
14K |
16 |
27/08/22 |
27/08/22 |
ASX - By Stock
|
33
|
14K
|
16
|
|
ASX - By Stock
|
FFF |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Jambon1
|
4 |
2.0K |
0 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
4
|
2.0K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene Protects Mouse Hearts from Chemotherapy Damage
|
|
Jambon1
|
112 |
41K |
58 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
112
|
41K
|
58
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Jambon1
|
76 |
27K |
42 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
76
|
27K
|
42
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Jambon1
|
76 |
27K |
60 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
76
|
27K
|
60
|
|
ASX - By Stock
|
OVT |
Re:
Ann: September Quarter Appendix 4C
|
|
Jambon1
|
89 |
41K |
0 |
30/10/21 |
30/10/21 |
ASX - By Stock
|
89
|
41K
|
0
|
|
ASX - By Stock
|
PLY |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Jambon1
|
25 |
13K |
2 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
25
|
13K
|
2
|
|
ASX - By Stock
|
PLY |
Re:
The New Australian RTS, Is Just Straight Up Good
|
|
Jambon1
|
12 |
6.5K |
1 |
20/10/21 |
20/10/21 |
ASX - By Stock
|
12
|
6.5K
|
1
|
|
ASX - By Stock
|
PLY |
Re:
The New Australian RTS, Is Just Straight Up Good
|
|
Jambon1
|
12 |
6.5K |
6 |
17/10/21 |
17/10/21 |
ASX - By Stock
|
12
|
6.5K
|
6
|
|
ASX - By Stock
|
PLY |
Re:
Ann: PlaySide & Team17 sign Long-Term Publishing Agreement
|
|
Jambon1
|
51 |
18K |
2 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
51
|
18K
|
2
|
|
ASX - By Stock
|
OVT |
Re:
Ann: Trading Halt
|
|
Jambon1
|
287 |
109K |
12 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
287
|
109K
|
12
|
|
ASX - By Stock
|
ZIP |
Re:
Daily Price Movement / General Discussion
|
|
Jambon1
|
46K |
11M |
0 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
46K
|
11M
|
0
|
|